Amphastar Pharmaceuticals Inc.

AMPH | NDAQ

Overview

Corporate Details

ISIN(s):: US03209R1032 (+3 more)
LEI:: 54930055TH0ZLSAQMJ38
Country:: United States of America
Address:: 850 NEW BURTON ROAD, 19904 DOVER
Website:: https://amphastar.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Amphastar Pharmaceuticals Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-03 00:00	Investor Presentation Wells Fargo Healthcare Presentation	English	3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Vivesto Develops therapies for hard-to-treat cancers in human and veterinary oncology.	Sweden	VIVE
WAKAMOTO PHARMACEUTICAL CO.,LTD.	Japan	4512
Xbrane Biopharma Develops affordable biosimilars for serious diseases using patented, high-yield production tech.	Sweden	XBRANE
Xspray Pharma Develops improved PKI cancer drugs using patented amorphous tech for earlier market entry.	Sweden	XSPRAY
Y.B Urban Renewal - Residential Development LTD	Israel	CSURE-M
YUKI GOSEI KOGYO CO.,LTD.	Japan	4531
Zelluna ASA Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.	Norway	ULTI
Zentiva 2 Develops and commercializes affordable generic, OTC, and biosimilar medicines for patients.	Slovakia	SKF
Zentiva S.A. Develops and distributes affordable generic, OTC, and specialty medicines across Europe.	Romania	SCD
ZERIA PHARMCEUTICAL CO., LTD.	Japan	4559